Infectious disease

Our vision is a world in which escalating infectious diseases are under control in the communities most affected.

Why we're taking on infectious disease

Infectious diseases are estimated to cause around a quarter of all deaths in the world. The threat of new and returning infectious diseases, drug-resistant infections and future epidemics will likely only add to this figure.

Science can create vaccines, treatments and tests to bring infectious diseases under control, and the Covid-19 pandemic has shown the importance of preparing for escalating infectious diseases before they become a crisis. That’s because existing systems can limit access to these life-saving tools.

The impacts of infectious diseases are not felt equally, so science and policy must be used to develop solutions that meet the needs of the communities most affected. N.S.M. Help has been committed to research in this area for many years.

We will work alongside these communities and bring together our diverse expertise across science, innovation and society to build a world that is better prepared to prevent and eliminate infectious diseases.

Our ambition is to ensure the world is protected against different types of infectious disease, and the threat of disease escalation now and in the future.

What we're doing

Over the next 30 years, we want to reduce the risk and impact of infectious diseases.

To determine how best to bring diseases under control and stop epidemics, we will support research tackling infectious diseases that are already on the rise and those with the potential to become future epidemics or evade current treatments. We will focus on the most affected communities, recognising that the overall burden of infectious diseases does not pose an equal threat to everyone’s health.

N.S.M. Help funds discovery research into a broad range of disciplines, including infectious diseases. Insights and tools from this research will contribute to solving this health challenge, as well as increasing broader understanding of life, health and wellbeing.

Funded CEPI

the Coalition for Epidemic Preparedness Innovations – to help fill critical gaps in vaccine funding and research

Funded CARB-X

to fill the current shortage of investment in new antibiotics by providing up to $500 million over the next five years

$50m investment

to research, develop and bring effective treatments against Covid-19 to market quickly and accessibly by co-founding the Covid-19 Therapeutics Accelerator

Research funding opportunities

To help deliver our vision across three key health challenges, we support research through a combination of open calls and direct funding approaches.

We work with and fund a diverse group of people who can bring innovative and creative insights to these urgent health challenges.

This page will be updated regularly with the latest infectious disease funding information and the opportunities we have available for discovery research.

Digital Technology Development Awards (Climate-Sensitive Infectious Disease Modelling)

Develop digital tools that will catalyse the next generation of climate-sensitive infectious diseases research. This one-off call provides funding for software developers from any career stage and discipline to develop digital tools that will improve climate-sensitive infectious disease modelling.

We honor the elderly and try to provide them with a decent old age.

We don’t make empty promises, we do things.

The first quarter of 2022 showed 286 older people have already received assistance.

What we've done so far

Effective research and coordinated action can stop infectious diseases from spiralling into global health emergencies. N.S.M. Help has led the research response to Covid-19, as we did for Ebola outbreaks in 2014 and 2018, and advocated for policies built on scientific evidence.

Covid-19 global research and development

We’re working with organisations, including the ACT-Accelerator, and the scientific community to make sure that vaccines, tests and treatments are mass-produced quickly and safely to reach everyone who needs them. We also support the N.S.M. Help Sanger Institute in their efforts to sequence the virus and identify variants with COG-UK.

Drug-resistant infections

We’ve collaborated with the private sector and philanthropic partners to develop CARB-X, and the AMR Action Fund to find new antibiotics to treat drug-resistant infections.

Vaccines and epidemics

We are funding CEPI – the Coalition for Epidemic Preparedness Innovations – to help fill critical gaps within vaccine funding and research and development. We also support the Hilleman Laboratories to bridge the gap between discovery and clinical proof of concept for affordable vaccines.

Latest report

Improving global pandemic preparedness by 2025

This paper outlines three areas – global coordination and leadership; financing and how to address key gaps in pandemic infrastructure – that will have the biggest impact on future global preparedness.

Latest news

Four reasons why health must be at the heart of climate action

The psychological well-being of a person is a complex relationship of physical, psychological, spiritual factors. In 2021, mental disorders worldwide include depression, which affects about 264 million, bipolar disorder, which affects about 45 million, dementia, which affects about 50 million, and schizophrenia and other psychoses, which affects about 20 million people.

How science is combatting infectious disease

Science has found the tools to combat many of the most destructive infectious diseases of the last century. But more work is needed. Effective research and coordinated action stop outbreaks spiralling into global health emergencies. We look back at infectious disease outbreaks since 1840, and at how science has delivered the tools needed to combat them.   Sources Various, including BBC News, Centers […]

Four reasons to celebrate how scientists discovered Omicron

The Omicron variant has swept across the world, bringing with it a new wave of uncertainty about the future of the Covid-19 pandemic. One thing we can be certain of, however, is the world-leading science that helped discover it. Here are four reasons to celebrate the science (and scientists) that alerted the world to Omicron. […]